tailieunhanh - Báo cáo khoa học: " Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: " Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer. | Radiation Oncology BioMed Central Short report Open Access Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy treatments of choice in patients with Non-Small Cell Lung Cancer Apollonia LJ Uitterhoeve 1 Mia GJ Koolen2 Rob M van Os1 Kees Koedooder1 Marlou van de Kar1 Bradley R Pieters1 and Caro CE Koning1 Address Department of Radiation Oncology Academic Medical Center University of Amsterdam Amsterdam The Netherlands and 2Department of Pulmonary Disease Academic Medical Center University of Amsterdam Amsterdam The Netherlands Email Apollonia LJ Uitterhoeve - Mia GJ Koolen - Rob M van Os - Kees Koedooder - Marlou van de Kar - Bradley R Pieters - Caro CE Koning - Corresponding author Published 23 July 2007 Received 14 May 2007 Radiation Oncology 2007 2 27 doi 1748-717X-2-27 Accepted 23 July 2007 This article is available from http content 2 1 27 2007 Uitterhoeve et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Results of high-dose chemo-radiotherapy CRT using the treatment schedules of EORTC study 08972 22973 or radiotherapy RT alone were analyzed among all patients pts with Non Small Cell Lung Cancer NSCLC treated with curative intent in our department from 1995-2004. Material Included are 131 pts with medically inoperable or with irresectable NSCLC TNM stage I 15 pts IIB 15 pts IIIA 57 pts IIIB 43 pts X 1 pt . Treatment Group I Concomitant CRT 66 Gy Gy 24 fractions fx 33 days combined with daily administration of cisplatin 6 mg m2 56 pts standard . Group II .

TÀI LIỆU LIÊN QUAN
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.